A Pilot Comparison of Phentermine and Diethylpropion for Treatment of Obesity

被引：0
|
作者：
Suboc, Gessa
Matesi, Gregory
Gilden, Adam
机构：
来源：
OBESITY | 2023年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
321
引用
下载
收藏
页码：181 / 181
页数：1
相关论文
共 50 条
  • [31] Addiction potential of phentermine prescribed during long-term treatment of obesity
    Hendricks, E. J.
    Srisurapanont, M.
    Schmidt, S. L.
    Haggard, M.
    Souter, S.
    Mitchell, C. L.
    De Marco, D. G.
    Hendricks, M. J.
    Istratiy, Y.
    Greenway, F. L.
    INTERNATIONAL JOURNAL OF OBESITY, 2014, 38 (02) : 292 - 298
  • [32] Phentermine in the Modern Era of Obesity Pharmacotherapy: Does It Still Have a Role in Treatment?
    Kristina H. Lewis
    Kimberly A. Gudzune
    Jamy D. Ard
    Current Obesity Reports, 2024, 13 : 132 - 140
  • [33] Comparison of weight loss, psychological and psychometric characteristics with dexfenfluramine/phentermine and fenfluramine/phentermine treatment in obese humans.
    Heuberger, RA
    Atkinson, RL
    FASEB JOURNAL, 1998, 12 (05): : A865 - A865
  • [34] DIETHYLPROPION HYDROCHLORIDE (TENUATE-DOSPAN) IN COMBINATION WITH HYPOTENSIVE AGENTS IN TREATMENT OF OBESITY ASSOCIATED WITH HYPERTENSION
    SEEDAT, YK
    REDDY, J
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1974, 16 (05): : 398 - 413
  • [35] Effects of liraglutide plus phentermine in adults with obesity following 1 year of treatment by liraglutide alone: A randomized placebo-controlled pilot trial
    Tronieri, Jena Shaw
    Wadden, Thomas A.
    Walsh, Olivia A.
    Berkowitz, Robert, I
    Alamuddin, Naji
    Gruber, Kathryn
    Leonard, Sharon
    Chao, Ariana M.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2019, 96 : 83 - 91
  • [36] The Use of Phentermine for Obesity in Psychiatric Patients With Antipsychotics
    Kim, Eunju
    Rim, Daniel
    Shin, Jeong-Hun
    Wong, Denise
    Kim, Dong Wook
    PSYCHIATRY INVESTIGATION, 2023, 20 (09) : 799 - 807
  • [37] DOUBLE-BLIND CLINICAL-TRIAL OF DIETHYLPROPION HYDROCHLORIDE, MAZINDOL, AND PLACEBO IN TREATMENT OF EXOGENOUS OBESITY
    ALLEN, GS
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1977, 22 (05): : 678 - 685
  • [38] New Obesity Agents: Lorcaserin and Phentermine/Topiramate
    Fleming, Joshua W.
    McClendon, Katie S.
    Riche, Daniel M.
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (7-8) : 1007 - 1016
  • [39] Comparison of Two Models of Family-Based Treatment for Childhood Obesity: A Pilot Study
    Bergmann, Kristie
    Mestre, Zoe
    Strong, David
    Eichen, Dawn M.
    Rhee, Kyung
    Crow, Scott
    Wilfley, Denise
    Boutelle, Kern N.
    CHILDHOOD OBESITY, 2019, 15 (02) : 116 - 122
  • [40] Cerebral hemorrhage in a patient taking fenfluramine and phentermine for obesity
    Wen, PY
    Feske, SK
    Teoh, SK
    Stieg, PE
    NEUROLOGY, 1997, 49 (02) : 632 - 633
12345